Articles by Sanjay Rao, MD - Ophthalmology Times Europe

ADVERTISEMENT

SEARCH
Articles by Sanjay Rao, MD

Sanjay Rao, MD


Sanjay Rao, MD is a speaker and receives research support from Allergan. He is on the scientific advisory board for EyeGate Pharmaceuticalsand he is a speaker for Bausch & Lomb.

Cyclosporine helps prevent progression of dry eye
September 1, 2009

A recent study showed that moderate to sever dry eye disease can be best treated with anti-inflammatory medications such as topical cyclosporine. According to one ophthalmologist, cyclosporine can significantly limit progression of dry eye disease and should be considered a 'go-to' therapy for this patient population.

REQUEST MEDIA KIT
To request your copy of the OTE media kit click here
OTE FAMILY
Visit Ophthalmology Times, our US sister publication
OTE e-NEWSLETTER

Click here to receive the free Ophthalmology Times Europe weekly e-newsletter

Click here